| HOME >> BIOLOGY >> TECHNOLOGY |
PerkinElmer Enters into Collaboration with BioLegend 28
Abbott Inks Agreement with BG Medicine 29
Ortho Clinical Diagnostics Receives FDA Approval for VITROS®
HBsAg Assay 29
Athera Inks Agreements with Oxford Biosystems and Asbach
Medical Products 30
CTI Acquires AVANT Immunotherapeutics 30
Clinical Genomics Enters into Global License Agreement with
Quest Diagnostics 30
Sigma-Aldrich Obtains Seppro Affinity Depletion Technology
from GenWay Biotech 31
Siemens to Merge with Siemens Healthcare Diagnostics 32
Merck Acquires Bangalore Genei 32
Commonwealth Biotechnologies to Purchase GL Biochem 32
Intercell Takes Over Iomai 32
Thermo Fisher Scientific Takes Over Open Biosystems 33
Thermo Fisher Scientific Acquires Affinity BioReagents 33
Daiichi Sankyo Takes Over U3 Pharma 33
IMUC Completes Molecular Antibody Technology Acquisition 34
EUSA Pharma to Take Over Cytogen 34
Access Pharmaceuticals Acquires Somanta Pharmaceuticals 35
Genmab Enters into Antibody Research Collaboration with Pepscan 35
BTI Enters into an Agreement with Raven 35
Eusa Sells Antibody Research Business 35
AVANIR Inks Definitive Agreement to Divest Anthrax Antibodies 36
CG Therapeutics and UoW Agree for Joint Monoclonal Antibody
Program 36
SDI to Develop mAbs for SAIC-F and NCI 36
Morphotek and HMI in Licensing Agreement 37
Amgen Enters into Licensing Agreement with Kyowa Hakko 37
Dyax and Sanofi-Aventis Sign Agreements 38
HGS Enters into Antibody Collaboration Agreement with Xencor 38
Biogen Partners with Genentech and Roche for Development of
GA-101 39
Tecan Commences Operations at Refurbished Facility 39
8. FOCUS ON SELECT PLAYERS 40
Abbott Diagnostics (UK) 40
Advanced ImmunoChemical
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |